Monday, October 22, 2007

BaroFeron™ Finds Manufacturing Home

BaroFold continues to march, achieving milestone after milestone. Congratulations are in order now for striking a process development and cGMP manufacturing agreement for their lead compound BaroFeron™ (interferon beta-1b) with Avecia Biologics.

Avecia will incorporate BaroFold's PreEMT™ hydrostatic pressure technology which enables improved, safer, proprietary protein therapeutics, providing product life-cycle extensions and creating new protein therapeutics through the use of a patented protein refolding technology.

Next up…complete scale-up and the drug manufacturing process.

If you enjoyed this post get free email updates (here).

No comments: